bucladesine has been researched along with Carcinoma, Thymic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalton, DK; Gruol, DJ | 1 |
| Bourguignon, LY; Butman, BT; Cabatu, OG; Jacobsen, T | 1 |
| Engels, P; Gruart-Gouilleux, V; Sullivan, M | 1 |
| Arai, K; Arai, N; Koyano-Nakagawa, N; Lee, HJ; Naito, Y; Nishida, J; Yokota, T | 1 |
| Chambers, DA; Graf, LH; Lancaster, SA; Wajeman-Chao, SA | 1 |
5 other study(ies) available for bucladesine and Carcinoma, Thymic
| Article | Year |
|---|---|
Phenothiazines cause a shift in the cAMP dose-response: selection of resistant variants in a murine thymoma line.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Cell Line; Drug Synergism; Female; Isoproterenol; Mice; Mice, Inbred BALB C; Nephelometry and Turbidimetry; Phenothiazines; Thymoma; Thymus Neoplasms; Trifluoperazine | 1984 |
The involvement of cAMP in lymphocyte capping.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Bucladesine; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Immunologic Capping; Lymphoma; Membrane Proteins; Mice; Rabbits; Rats; Theophylline; Thymoma | 1981 |
Characterization of the human interleukin-5 gene promoter: involvement of octamer binding sites in the gene promoter activity.
Topics: Animals; Base Sequence; Binding Sites; Bucladesine; Calcimycin; Consensus Sequence; Gene Expression Regulation; Genes; Genes, Reporter; Humans; Interleukin-5; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Point Mutation; Promoter Regions, Genetic; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thymoma; Thymus Neoplasms; Transcription Factors; Transfection; Tumor Cells, Cultured | 1995 |
cAMP activates the IL-5 promoter synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4.
Topics: Animals; Bucladesine; Cyclic AMP-Dependent Protein Kinases; Drug Synergism; Gene Expression Regulation; Interleukin-2; Interleukin-5; Mice; Promoter Regions, Genetic; T-Lymphocytes, Helper-Inducer; Tetradecanoylphorbol Acetate; Thymoma; Transfection; Tumor Cells, Cultured | 1993 |
Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-lineage cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bucladesine; Cell Lineage; Cells, Cultured; Cholera Toxin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Half-Life; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Models, Biological; Norepinephrine; Propranolol; Receptors, Adrenergic, beta; RNA, Messenger; Second Messenger Systems; Specific Pathogen-Free Organisms; T-Lymphocytes; Thy-1 Antigens; Thymoma; Thymus Gland; Thymus Neoplasms; Tumor Cells, Cultured | 1998 |